D-penicillamine and retinopathy of prematurity

To the Editor.— The letter to the editor by Johnson et al1 and studies by others regarding vitamin E prophylaxis for retinopathy of prematurity suggest that further research into the prevention of retinopathy of prematurity should not be limited to vitamin E. On the basis of clinical observations we...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 1988-12, Vol.82 (6), p.951-952
Main Author: Lakatos, L
Format: Article
Language:English
Subjects:
Humans
Infant, Newborn
Penicillamine - therapeutic use
Retinopathy of Prematurity - prevention & control
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To the Editor.— The letter to the editor by Johnson et al1 and studies by others regarding vitamin E prophylaxis for retinopathy of prematurity suggest that further research into the prevention of retinopathy of prematurity should not be limited to vitamin E. On the basis of clinical observations we reported that d-penicillamine treatment in the neonatal period was associated with a marked decrease in the incidence of severe retrolental fibroplasia among the very low birth weight infants.2
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.82.6.951a